Using historical data to facilitate clinical prevention trials in Alzheimer disease? An analysis of longitudinal MCI (mild cognitive impairment) data sets

Ítems similars

• Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression
  per: Beck, Irene R, et al.
  Publicat: (2014)
• The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline
  per: Mistridis, Panagiota, et al.
  Publicat: (2015)
• For debate: substituting placebo controls in long-term Alzheimer's prevention trials
  per: Spiegel, René, et al.
  Publicat: (2011)
• A Novel Study Paradigm for Long-term Prevention Trials in Alzheimer Disease: The Placebo Group Simulation Approach (PGSA): Application to MCI data from the NACC database
  per: Berres, M., et al.
  Publicat: (2014)
• The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's disease and their Association with White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set
  per: Anor, Cassandra J., et al.
  Publicat: (2020)